Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2012
09/12/2012CN101829051B 1'-acetoxychavicol acetate injection
09/12/2012CN101773668B Antivirus associated protein and application thereof
09/12/2012CN101760446B Method for preparing monocyte type stem cell and application
09/12/2012CN101715956B Multifunctional health juice with stable effective ingredients and processing method thereof
09/12/2012CN101583598B Novel indole derivative having inhibitory activity on i kappa b kinase
09/12/2012CN101579522B Novel peptide-based vaccine used for domestic animal and preparation method thereof
09/12/2012CN101385845B Traditional Chinese medicine preparation for treating hepatitis B
09/12/2012CN101209252B Use of aloperine in preparing medicament for treating chronic hepatitis B
09/12/2012CN101204445B Soft capsule for hepatitis and preparation method thereof
09/11/2012US8263761 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof
09/11/2012US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide
09/11/2012US8263600 Antifungal composition with enhanced bioavailability
09/11/2012US8263594 Aryloxy and arylalkyleneoxy substituted imidazoquinolines
09/11/2012US8263560 HPV 16 peptide vaccine for head and neck cancer
09/11/2012US8263326 Compounds and methods for modulating activation of NF-κB
09/11/2012US8263114 mixture of silicone fluid , silica and drug; wound dressing; topical applying; drug delivery
09/11/2012US8263111 Non-hormonal vaginal contraceptive
09/11/2012US8263089 Compounds and methods for treatment and diagnosis of chlamydial infection
09/11/2012US8263070 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders
09/11/2012CA2627740C Preparation of a crystalline antibiotic substance
09/11/2012CA2551640C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
09/11/2012CA2549851C Macrocyclic peptides active against the hepatitis c virus
09/11/2012CA2547032C Vaccine comprising an antigen conjugated to low valency anti-cd40 or anti-cd28 antibodies
09/11/2012CA2526570C Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
09/11/2012CA2491726C Feline infectious peritonitis vaccine
09/11/2012CA2475218C Preparation for oxidation-sensitive compounds and method for making same
09/11/2012CA2474402C Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
09/11/2012CA2442865C Vaccine composition
09/11/2012CA2428027C Yeast derived vaccine against ipnv
09/11/2012CA2423004C Peptide inhibitors of hiv entry
09/11/2012CA2395291C Five-helix protein
09/11/2012CA2326407C Retroviral vectors including modified envelope escort proteins
09/07/2012WO2012118599A1 C-abl tyrosine kinase inhibitors useful for inhibiting filovirus replication
09/07/2012WO2012118535A1 Materials and methods for treating conditions associated with pathogenic biofilm
09/07/2012WO2012118154A1 Novel vitamin d receptor modulator with partial agonist activity
09/07/2012WO2012118124A1 Novel chemokine receptor antagonist
09/07/2012WO2012118092A1 Fusion protein
09/07/2012WO2012118070A1 Anti-gram-negative bacteria agent
09/07/2012WO2012118048A1 Novel macrolide intermediate and novel production process
09/07/2012WO2012117048A1 Pharmaceutically active disubstituted triazine derivatives
09/07/2012WO2012116452A1 Antimicrobial/adjuvant compounds and methods
09/07/2012WO2012116447A1 Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
09/07/2012WO2012094360A3 Biotherapeutics for the treatment of infectious diseases
09/07/2012WO2012093855A3 Novel flavi mycin compound, antifungal composition including same, and method for producing same
09/07/2012WO2012057575A3 Feed additive composition containing turmeric extracts and stevia extracts as active ingredients for increasing resistance to white spot syndrome viruses, and feed composition comprising same
09/07/2012WO2012039642A8 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
09/07/2012WO2012026908A3 Cefpodoxime proxetil formulations comprising taste regulating agent
09/07/2012WO2012023033A3 Mch-i restricted epitopes containing non-natural amino acid residues
09/07/2012CA2828748A1 Antimicrobial / adjuvant compounds and methods
09/07/2012CA2828612A1 Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
09/07/2012CA2826464A1 Pharmaceutically active disubstituted triazine derivatives
09/06/2012US20120225935 Antimicrobial and radioprotective compounds
09/06/2012US20120225931 Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods
09/06/2012US20120225923 Dithiinetetra(thio)carboximides
09/06/2012US20120225911 Replenishing body stores of fat-soluble vitamins A, and D eradicate chronic viral infection
09/06/2012US20120225903 Novel 2-Substituted Quinoline Derivatives, And Method For Preparing Same
09/06/2012US20120225894 Substituted Thienol[2,3-d] pyrimidines as HIV Inhibitors
09/06/2012US20120225889 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
09/06/2012US20120225888 Inhibitors of Human Immunodeficiency Virus Replication
09/06/2012US20120225883 Compounds for inflammation and immune-related uses
09/06/2012US20120225879 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases
09/06/2012US20120225875 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
09/06/2012US20120225855 Triazolopyridine jak inhibitor compounds and methods
09/06/2012US20120225850 Steroidal antitubercular compounds
09/06/2012US20120225847 Squaric acid derivatives as inhibitors of the nicotinamide
09/06/2012US20120225839 Phosphoramidate Derivatives of Nucleosides
09/06/2012US20120225837 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent
09/06/2012US20120225835 Antibiotic formulations, unit doses, kits, and methods
09/06/2012US20120225826 Transporters Comprising Spaced Arginine Moieties
09/06/2012US20120225809 Compounds for treating papilloma virus infection
09/06/2012US20120225808 Pharmaceutical Composition for Preventing / Treating TRPV1 Activity-Related and Inflammation-Related Diseases or Conditions Containing Maillard Peptide Separated from Well-Aged Traditional Soy Sauce as Active Ingredient
09/06/2012US20120225402 Novel dental appliances and methods for their fabrication
09/06/2012US20120225143 Cold sore formulation and related method of manufacture
09/06/2012US20120225137 Antimicrobial & antiviral composition
09/06/2012US20120225128 Method for carrying therapeutic substances into cells
09/06/2012US20120225117 Process for production of w/o/w emulsion, process for production of liposome employing the process, and porous membrane for use in the processes
09/06/2012US20120225114 Modifying Macrophage Phenotype for Treatment of Disease
09/06/2012US20120225113 Method for treating tuberculosis
09/06/2012US20120225107 Stable skin and scar treatment composition
09/06/2012US20120225102 Perfluorocarbon gel formulations
09/06/2012US20120225101 Multifunctional in situ polymerized network via thiol-ene and thiol-maleimide chemistry
09/06/2012US20120225100 Articlea and processes for Making a Porous Disintegratable Solid Substrate for Personal Health Care Applications
09/06/2012US20120225098 Biofilm inhibiting composition
09/06/2012US20120225097 Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
09/06/2012US20120225093 Abrogating HIV-1 Infection via Drug-Induced Reactivation of Apoptosis
09/06/2012US20120225091 Modified live (jmso strain) haemophilus parasuis vaccine
09/06/2012US20120225083 Viral polypeptides and methods
09/06/2012US20120225074 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
09/06/2012US20120225068 Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza a (h1n1) virus (s-oiv) infections
09/06/2012US20120225067 Composition and Method for Mediating an Immune Response
09/06/2012US20120225064 Sphingosine 1-Phosphate Antagonism
09/06/2012US20120225058 Novel immunoglobulin insertions, deletions, and substitutions
09/06/2012US20120225057 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
09/06/2012US20120225053 Compositions and methods for the prevention and treatment of conditions associated with inflamation
09/06/2012US20120225050 Methods for improving gut health
09/06/2012US20120225043 Enhancement of Immune Responses By 4-1BB-Binding Agents
09/06/2012US20120225042 Competitive exclusion composition and methods
09/06/2012US20120225037 Sporulation-Deficient B. texasporus Cells and Methods for Efficient and Cost-effective Inactivation and Use Thereof
09/06/2012US20120225035 Antifungal mixture with fungal organism pythium oligandrum
09/06/2012US20120225030 Uses of mammalian cytokine; related reagents
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 1798